Bio Pharma Dive
MARCH 21, 2022
Opdualag is first approved drug that works by targeting a protein called LAG-3 and the third type of "checkpoint inhibitor" the agency has cleared for cancer.
World of DTC Marketing
MARCH 21, 2022
An increasing number of headlines amplifying many incomplete data around telehealth have led industry stakeholders to extrapolate discrete data points about telehealth to the entire U.S. population. Using an economic framework to analyze national telehealth data. Only 25.6% of Americans utilized telehealth during the two years of the pandemic. Said another way, investments in the telehealth market have been made on the thesis that telehealth is preferred among most Americans.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 21, 2022
As Omicron cases continue to decline and hopes for a return to normalcy rise once again, it's tempting to let your guard down. Emergent team members reflect on lessons learned through COVID-19 and share four considerations to help prepare for the next public health threat.
Pharma Times
MARCH 21, 2022
Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
MARCH 21, 2022
Nearly 20 years since its founding, Marinus Pharmaceuticals will make the leap to a commercial-stage biotechnology company with Friday's approval of Ztalmy.
Scienmag
MARCH 21, 2022
Deaths from cancer are expected to increase over the next decade as a result of screening deficits due to the COVID-19 pandemic. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals the extent of screening deficits in breast, colorectal, lung, and cervical cancers across the United States […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioPharma Reporter
MARCH 21, 2022
Moderna announced a new supply agreement with the Swiss federal government today for seven million doses of its COVID-19 booster vaccine for anticipated delivery in 2023.
Scienmag
MARCH 21, 2022
HOUSTON – (March 21, 2022) – Texas can be a model for the nation on how to effectively replace coal with wind and solar for the state’s energy needs while meeting environmental goals, according to new research by Rice University engineers. Credit: Wikipedia HOUSTON – (March 21, 2022) – Texas can be a model for […].
XTalks
MARCH 21, 2022
After 17 years as a plant-based brand, Coconut Bliss has added a dairy-based ice cream to its product lineup. Founded in 2005, Coconut Bliss was once ahead of its time with recognizing the power and soon-to-be popularity of plant-based dairy options. Now, rebranded as Cosmic Bliss, the brand is attempting to boost sustainable dairy with its organic, grass-fed, clean-label dairy ice cream line. .
pharmaphorum
MARCH 21, 2022
Takeda has secured UK approval for its lung cancer therapy Exkivity, with an NHS access deal that could see it prescribed to patients within the next few weeks. The Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorisation to Exkivity (mobocertinib) as a monotherapy for non-small-cell lung cancer (NSCLC) patients whose tumours have EGFR exon20 insertion mutations, after first-line chemotherapy.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
MARCH 21, 2022
Credited as a pioneering RNA interference (RNAi) therapeutics company, Alnylam Pharmaceuticals is taking Pfizer and Moderna to court, claiming that the companies’ use of the lipid nanoparticle (LNP)-based RNA delivery technology in their mRNA COVID-19 vaccines infringes on a patented technology. Alnylam filed lawsuits against each company in a Delaware federal court on Thursday.
pharmaphorum
MARCH 21, 2022
The International Virtual Reality Healthcare Association (IVRHA) held its 6th annual conference in Nashville, Tennessee, showcasing medical extended reality (XR) experiences and the companies impacting the healthcare ecosystem. As Adam Elsesser, CEO of Penumbra, stated in his keynote, when many people think of virtual reality, they often think of gaming.
Scienmag
MARCH 21, 2022
Magnetic interactions could point to miniaturizable quantum devices. Credit: (Image by Yi Li/Argonne National Laboratory.) Magnetic interactions could point to miniaturizable quantum devices. From MRI machines to computer hard disk storage, magnetism has played a role in pivotal discoveries that reshape our society. In the new field of quantum computing, magnetic interactions could play a role in […].
Pharma Times
MARCH 21, 2022
Research analysed differences in treatment and survival between women and men with a heart attack and cardiogenic shock
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
MARCH 21, 2022
When the Swedish government and mining company LKAB (Luossavaara-Kiirunavaara AB) first shared responsibility for developing the city of Kiruna over a hundred years ago, they focused mostly on practical issues. How does one build a city in a “desolate wilderness”? How does one attract settlers to a new place, far away in the Arctic north? […].
Drug Channels
MARCH 21, 2022
Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $204 billion for patent-protected brand-name drugs in 2021. If we include brand-name drugs that have lost patent protection and face competition from generic equivalents, the bubble was even higher, at $236 billion.
Scienmag
MARCH 21, 2022
PHILADELPHIA, March 21, 2022 – Children in the Greater Philadelphia area face a number of environmental threats to their health, including lead poisoning, asthma from air pollution, and exposure to endocrine disrupting chemicals. Now, with funding from the National Institute of Environmental Health Sciences, researchers from Children’s Hospital of Philadelphia (CHOP) and Penn Medicine have come […].
pharmaphorum
MARCH 21, 2022
Bristol-Myers Squibb is the first big pharma to strike a deal with Volastra Therapeutics, a start-up that has developed a drug discovery platform based on chromosomal instability (CIN), a common but under-investigated feature of solid tumours. BMS is paying $30 million into the collaboration upfront, with a total deal value of $1.1 billion, for programmes addressing up to three undisclosed targets in cancer therapy.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MARCH 21, 2022
Suppose that we could watch twenty generations of whales or sharks adapting to climate change—measuring how they evolve and how their biology changes as temperatures and carbon dioxide levels rise. That could tell us a lot about how resilient life in the oceans might be to a warmer world. But it would also take hundreds […].
Client Pharma
MARCH 21, 2022
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on.
Scienmag
MARCH 21, 2022
A novel screening platform has flagged more than 95 percent of stage 1 cancers, according to a pilot study published in Nature Communications Medicine. If validated by future studies, the approach offers a new way to detect the third-leading cause of U.S. cancer deaths in 2020. Credit: UC San Diego Health Sciences A novel screening platform […].
Roots Analysis
MARCH 21, 2022
Over the years, the incidence and prevalence of chronic diseases, have increased significantly. Presently, the recommended treatment options for such clinical conditions are mostly biologics, which need to be administered via parenteral routes to ensure maximum therapeutic benefit. Given the inherent requirement for frequent medication, patients suffering from such long-lasting clinical conditions generally end up spending high amounts on the prescribed therapeutic regimen, and numerous hospital
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MARCH 21, 2022
If you have eaten a chili pepper, you have likely felt how your body reacts to the spicy hot sensation. New research published by biologists at the University of Oklahoma shows that the brain categorizes taste, temperature and pain-related sensations in a common region of the brain. The researchers suggest the brain also groups these […].
The Pharma Data
MARCH 21, 2022
On World TB Day, WHO calls for an urgent investment of resources, support, care and information into the fight against tuberculosis (TB). Although 66 million lives have been saved since 2000, the COVID-19 pandemic has reversed those gains. For the first time in over a decade, TB deaths increased in 2020. Ongoing conflicts across Eastern Europe, Africa and the Middle East have further exacerbated the situation for vulnerable populations.
Scienmag
MARCH 21, 2022
LAWRENCE, KANSAS – Think of the Duke of Lennox as a politician who appears on “Dancing With the Stars.” Ludovic Stuart, the duke, did much the same thing when he capered at 17th-century masques — that is, elaborate royal court performances — in the Banqueting Hall he helped build in London for his patron, King […].
Pharma in Brief
MARCH 21, 2022
The Minister of Health has issued a new interim order regarding expedited authorizations for COVID-19-related medical devices. Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 ( IO No. 3 ) maintains all of the flexibilities of its predecessor, including the consideration of urgent public health needs ( UPHN ).
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MARCH 21, 2022
Wilmington, DE, (MARCH 21, 2022) – A new study from scientists at ChristianaCare’s Gene Editing Institute is advancing the safety and efficacy of using CRISPR gene editing in patient treatments by demonstrating how to identify and evaluate the broad-based biological impact of gene editing on targeted tissues, where the edits are designed to fully disable […].
The Pharma Data
MARCH 21, 2022
Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake (ADI) level.
Scienmag
MARCH 21, 2022
An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according to a study published online Mar. 16 in Science Translational Medicine. Based on their initial results, the antibody appears to be a promising candidate for developing a “pan-hantavirus” therapy to protect against outbreaks caused by […].
The Pharma Data
MARCH 21, 2022
Today, the U.S. Food and Drug Administration is announcing a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wed., April 6, to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and emerging variants.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
255 
Let's personalize your content